CCN2 and colorectal cancer: Moreover, a high expression of MMP3 was prognostically unfavorable in pancreatic cancer (p = 0.00041), cervical cancer (p = 0.00097), and prostate cancer (p = 0.033) (Figure 9E,F; Table 3) while a high expression of CCN2/CTGF was prognostically unfavorable in stomach cancer (p = 0.0005), urothelial cancer (p = 0.0038), and colorectal cancer (p = 0.044) (Figure 9G,H; Table 4).